Sign Up to like & get
recommendations!
1
Published in 2018 at "Drug discovery today"
DOI: 10.1016/j.drudis.2016.05.003
Abstract: Is preclinical data sharing the new norm? In my experience, it is certainly becoming more commonplace. However, it is not yet standard practice and remains the preserve of special projects. Here, I expound the benefits…
read more here.
Keywords:
new norm;
data sharing;
preclinical data;
sharing new ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2019.06.003
Abstract: Ovarian cancer is the deadliest gynecologic malignancy, and relapse after initial treatment is frequently fatal. Although ovarian cancer typically has an immunosuppressive tumor microenvironment, a strong intratumoral T cell presence is associated with an improved…
read more here.
Keywords:
checkpoint inhibitors;
use;
ovarian cancer;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-5566
Abstract: The retinoic acid-related orphan receptor γt (RORγt) is a nuclear receptor transcription factor that acts as an immune cell master control switch driving the generation and function of Th17 (helper) and Tc17 (cytotoxic) T cells.…
read more here.
Keywords:
clinical combinations;
ror;
ror agonist;
lyc 55716 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2020 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2020.603409
Abstract: Gene therapy to treat pharmacoresistant temporal lobe epilepsy in humans is now being developed using an AAV vector (CG01) that encodes the combination of neuropeptide Y and its antiepileptic receptor Y2. With this in mind,…
read more here.
Keywords:
vector;
cg01;
gene therapy;
preclinical data ... See more keywords